No abstract available
MeSH terms
-
Atherosclerosis / complications*
-
Cardiovascular Diseases / drug therapy
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / etiology*
-
Fibrinolytic Agents / therapeutic use
-
Health Promotion*
-
Humans
-
Hypolipidemic Agents / therapeutic use
-
Obesity / complications
-
Risk Assessment
-
Thrombosis / complications*
Substances
-
Fibrinolytic Agents
-
Hypolipidemic Agents